Ovarian and breast cancer are two of the most common cancers affecting women. While they occur in different parts of the body, there is a strong biological link between them—especially through genetics.
A key connection is mutations in the BRCA1 and BRCA2 genes. According to the American Cancer Society, women with breast cancer have twice the risk of developing ovarian cancer compared to the general population.
Research shows that women with a BRCA1 mutation have up to a 72% lifetime risk of breast cancer and up to a 44% risk of ovarian cancer. For those with a BRCA2 mutation, the risks are up to 69% for breast cancer and 17% for ovarian cancer.
These gene mutations can be inherited from either parent, making family history of either cancer a significant risk factor—even if no family member has had both types.
Women from families with multiple cases of breast or ovarian cancer may benefit from genetic testing. Understanding your genetic makeup can guide preventive strategies and early detection plans with your healthcare provider.
Other shared risk factors include age, obesity, not having children, and long-term hormone replacement therapy after menopause.
To reduce cancer risk, some high-risk individuals consider preventive surgeries, such as a mastectomy or oophorectomy, which involve the removal of breasts, ovaries, and fallopian tubes.
Early awareness, genetic insight, and medical guidance can be powerful tools in managing cancer risk and protecting long-term health
The link between ovarian and breast cancer has been an important area of medical research, particularly because both diseases share certain genetic, hormonal, and lifestyle risk factors. While ovarian cancer affects the ovaries and breast cancer develops in breast tissue, studies have shown that women with one of these cancers have a higher risk of developing the other. This connection is most clearly understood through the role of inherited gene mutations, particularly in the BRCA1 and BRCA2 genes.
Genetic Connection: BRCA Mutations
The BRCA1 and BRCA2 genes are responsible for producing proteins that help repair damaged DNA. When these genes carry harmful mutations, they fail to repair DNA effectively, increasing the likelihood of abnormal cell growth and cancer formation. Women with BRCA1 mutations have a significantly higher lifetime risk—up to 65% for breast cancer and up to 39% for ovarian cancer. BRCA2 mutations also raise the risk, though the percentages differ slightly. These mutations can be inherited from either parent, meaning family history on both the mother’s and father’s side is important to consider.
Family History and Screening
If a woman has multiple close relatives diagnosed with breast or ovarian cancer—especially at a young age—it may indicate a hereditary cancer syndrome. Genetic testing for BRCA and other mutations, such as those in the PALB2 or TP53 genes, can help determine risk. For women who test positive, enhanced surveillance, risk-reducing medications, or preventive surgeries may be considered. For example, a prophylactic mastectomy can lower breast cancer risk, and the removal of ovaries and fallopian tubes (salpingo-oophorectomy) can greatly reduce ovarian cancer risk.
Hormonal and Reproductive Factors
Apart from genetics, certain hormonal and reproductive factors contribute to the link. Both ovarian and breast cancer are influenced by lifetime exposure to estrogen. Factors such as early menstruation, late menopause, not having children, or having a first child after age 35 can increase cumulative estrogen exposure and raise cancer risk. Hormone replacement therapy (HRT), particularly combined estrogen-progestin regimens, has been associated with higher risks of both cancers in some women.
Lifestyle and Environmental Factors
Lifestyle choices also play a role in the connection between these cancers. Obesity, excessive alcohol consumption, and lack of physical activity are associated with increased risk for both diseases. Maintaining a healthy body weight, engaging in regular exercise, limiting alcohol, and eating a balanced diet rich in fruits, vegetables, and whole grains can help lower overall cancer risk.
Importance of Early Detection
Breast cancer often has more established screening tools—such as mammography—than ovarian cancer, which is often detected at later stages due to vague symptoms like bloating, abdominal pain, or changes in appetite. For women at high genetic risk, combining breast cancer screening with ovarian cancer surveillance, such as transvaginal ultrasounds or CA-125 blood tests, may help detect problems earlier, though these methods are not foolproof.
Conclusion
The link between ovarian and breast cancer is strongest in women with BRCA1 and BRCA2 mutations, but hormonal, reproductive, and lifestyle factors also contribute. Understanding personal risk through family history and genetic testing allows women to take proactive measures, from lifestyle adjustments to preventive medical interventions. By recognizing the shared risk factors, doctors and patients can work together on tailored screening and prevention strategies, ultimately improving early detection and outcomes for both diseases.
If you want, I can also make a clear diagram showing how BRCA mutations link breast and ovarian cancer to make it easier to understand visually.
